Efficacy of in-vivo counting in parathyroid radioguided surgery and usefulness of its association with scintigraphy and intraoperative PTHi
[EN]Aim: To evaluate the efficacy of the γ probe, alone and in combination with other techniques, in primary hyperparathyroidism surgery, as well as its ability to distinguish between single-gland and multiple-gland diseases. Materials and methods: Sixty-three patients with primary hyperparathyroidi...
| Autores: | , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2011 |
| País: | España |
| Institución: | Universidad de Salamanca (USAL) |
| Repositorio: | GREDOS. Repositorio Institucional de la Universidad de Salamanca |
| OAI Identifier: | oai:gredos.usal.es:10366/166668 |
| Acceso en línea: | http://hdl.handle.net/10366/166668 |
| Access Level: | acceso embargado |
| Palabra clave: | Technetium-99m methoxyisobutylisonitrile C probe, in-vivo counting Intraoperative intact parathyroid hormone Parathyroid scintigraphy Parathyroid surgery In-vivo counting Hyperparathyroidism, Primary Radiosurgery Technetium Tc 99m Sestamibi 32 Ciencias Médicas radiocirugía sestamibi de tecnecio Tc 99m hiperparatiroidismo primario |
| Sumario: | [EN]Aim: To evaluate the efficacy of the γ probe, alone and in combination with other techniques, in primary hyperparathyroidism surgery, as well as its ability to distinguish between single-gland and multiple-gland diseases. Materials and methods: Sixty-three patients with primary hyperparathyroidism submitted to radioguided parathyroidectomy, with a minimum follow-up of 1 year, were included. A preoperatory scintigraphy with technetium-99m methoxyisobutylisonitrile was performed in all cases and the excised specimens were histopathologically examined. Intraoperative intact parathyroid hormone (ioPTHi) data were available for 59 patients. Results: Sixty-three patients underwent radioguided parathyroidectomy: 30 minimally invasive radioguided parathyroidectomy, 18 unilateral, and 15 bilateral surgeries. A receiver operating characteristic curve analysis was carried out to distinguish between normal and pathological glands. Using a cut-off value of 1.15 for the γ-probe in-vivo index, we obtained 87% sensitivity, 95% specificity, and 97% positive predictive value (PPV). There were statistically significant differences among in-vivo indexes sorted by type of gland histology (Kruskall-Wallis; P=0.001). A receiver operating characteristic curve was again used to discriminate between single-gland and several-gland pathologies. For a cut-off of 1.51, we achieved 67% sensitivity, 87% specificity, and 95% PPV. Conclusion: Pathological glands can be detected by the γ probe (in-vivo index>1.15) with a PPV of 97%. Although an in-vivo index greater than 1.51 is suggestive of a solitary adenoma (PPV=95%), there are a significant number of cases (27%) with lower indexes, these would erroneously lead to an extended surgery in search of a multiglandulary disease. For this reason, the combined determination of the intraoperative intact parathyroid hormone is recommended to identify multiglandulary disease. |
|---|